Next Financial Group’s Arbutus Biopharma ABUS Stock Holding History

Next Financial Group’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$1K	–	2845
2021 Q3	$1K	Hold	200	–	–	﹤0.01%	2556
2021 Q2	$1K	Hold	200	–	–	﹤0.01%	2475
2021 Q1	$1K	Hold	200	–	–	﹤0.01%	2358
2020 Q4	$1K	Hold	200	–	–	﹤0.01%	2241
2020 Q3	$1K	Buy	+200	New	+$608	﹤0.01%	2076
2020 Q2	–	Sell	-200	Closed	–	–	601
2020 Q1	$0	Hold	200	–	–	﹤0.01%	2092
2019 Q4	$1K	Hold	200	–	–	﹤0.01%	2243
2019 Q3	$0	Buy	+200	New	+$345	﹤0.01%	2289
2019 Q2	–	Sell	-200	Closed	-$1K	–	2287
2019 Q1	$1K	Hold	200	–	–	﹤0.01%	1529
2018 Q4	$1K	Hold	200	–	–	﹤0.01%	1813
2018 Q3	$2K	Buy	+200	New	+$1.99K	﹤0.01%	1291
2017 Q4	–	Sell	-200	Closed	-$1K	–	283
2017 Q3	$1K	Hold	200	–	–	﹤0.01%	1663
2017 Q2	$1K	Hold	200	–	–	﹤0.01%	1803
2017 Q1	$1K	Hold	200	–	–	﹤0.01%	1772
2016 Q4	$0	Hold	200	–	–	﹤0.01%	2361
2016 Q3	$1K	Hold	200	–	–	﹤0.01%	2238
2016 Q2	$0	Hold	200	–	–	﹤0.01%	1728
2016 Q1	$0	Hold	200	–	–	﹤0.01%	1708
2015 Q4	$0	Hold	200	–	–	﹤0.01%	1760
2015 Q3	$1K	Hold	200	–	–	﹤0.01%	1679
2015 Q2	$2K	Hold	200	–	–	﹤0.01%	1643
2015 Q1	$3K	Hold	200	–	–	﹤0.01%	1592
2014 Q4	$3K	Sell	200 -700	-78%	-$12.1K	﹤0.01%	1620
2014 Q3	$19K	Buy	+900	New	+$14.7K	﹤0.01%	1439

Other funds holding ABUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

Next Financial Group's ABUS Position: Q4 2021 in Review

Next Financial Group sold out of Arbutus Biopharma (ABUS) in Q4 2021, closing a stake of 200 shares — an estimated $1K sold.

Next Financial Group first reported a position in ABUS in Q3 2014 and held it in 24 quarters. The position peaked at $19K in Q3 2014. 122 funds tracked by Wall St. Rank hold ABUS as of Q4 2021.

Next Financial Group reported no remaining Arbutus Biopharma position as of Q4 2021 after selling out during the quarter.
Next Financial Group sold 200 Arbutus Biopharma shares in Q4 2021, an estimated $1K.
Next Financial Group first reported a position in Arbutus Biopharma in Q3 2014 and held it in 24 quarters.
Next Financial Group's Arbutus Biopharma position peaked at $19K in Q3 2014.
122 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.